Skip to main content

Table 3 Changes in the levels of inflammatory markers of patients in the group A and B

From: Changes in the levels of inflammatory markers after transthoracic device closure of ventricular septal defects in pediatric patients

item

preOP

POD1

POD2

POD3

POD5

POD7

WBC

A

8.4 ± 1.8

16.7 ± 2.8

15.4 ± 1.9

13.2 ± 2.2

9.7 ± 4.0

8.4 ± 0.9

B

7.4 ± 2.8

15.9 ± 2.1

16.1 ± 2.6

13.6 ± 2.0

10.8 ± 1.6

8.4 ± 0.9

P

0.08

0.38

0.12

0.41

0.10

0.81

PCT

A

0.36 ± 0.15

9.24 ± 3.34

8.91 ± 1.55

4.84 ± 1.22

0.77 ± 0.18

0.41 ± 0.2

B

0.32 ± 0.09

8.37 ± 1.08

9.42 ± 0.90

5.57 ± 2.06

0.81 ± 0.10

0.44 ± 0.1

P

0.14

0.1

0.07

0.06

0.23

0.37

CRP

A

0.76 ± 0.7

58.6 ± 28.2

127 ± 27.8

41.9 ± 34.6

17.4 ± 9.3

4.70 ± 2.9

B

1.2 ± 1.3

68.7 ± 26.7

133 ± 25.5

57.2 ± 43.3

20.3 ± 8.5

5.40 ± 3.8

P

0.11

0.10

0.26

0.08

0.13

0.34

IL-6

A

2.9 ± 1.4

189 ± 25.8

66.8 ± 22.0

27.3 ± 26.6

10.1 ± 8.2

8.3 ± 1.6

B

3.4 ± 1.1

196 ± 21.3

72.9 ± 18.7

37.3 ± 27.4

15.1 ± 14.7

10.2 ± 6.7

P

0.10

0.17

0.18

0.10

0.07

0.10

  1. A = group A, B = group B